Biotech Specialty Pharma

InVivo Therapeutics

One Broadway, 14th Floor
Cambridge, MA 02141 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Developing and intends to commercialize groundbreaking technologies for the treatment of spinal cord injuries (SCI).

Management Frank Reynolds, Chairman of the Board and CEO; Dr. Eric J. Woodard, MD, Chief Medical Officer; Dr. Ed Wirth III, M.D., Ph.D., Chief Science Officer

Click here for Financial Data
Keywords: Surgery, Stem Cells, Neurology, Neurological, spinal cord, SCI,


Updated: Apr. 06, 2017


InVivo has an unmatched development portfolio composed of platform technologies for the treatment of both spinal cord injury and other application. These technologies encompass multiple strategies inv......view more

Products / Services

InVivo Therapeutics is focused on utilizing polymers as a platform technology to develop and commercialize groundbreaking treatments for spinal cord injuries (SCI). InVivos technologies encompasses......view more

Technology / Differentiation

InVivo intends to create a new paradigm of care by taking a novel approach to SCI. Instead of focusing exclusively on regeneration, InVivo concentrates on neuroprotection. Our products are intended to...view more

Market / Customers

Currently, there are no treatment options for SCI patients to successfully restore function following a spinal cord injury. Existing treatments consist of a collection of approaches that only focus on......view more


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in /home/onemedpl/public_html/include/counter.php:10 Stack trace: #0 /home/onemedpl/public_html/database/comp_profile_include.php(1079): include() #1 /home/onemedpl/public_html/database/comp_profile.php(87): include('/home/onemedpl/...') #2 {main} thrown in /home/onemedpl/public_html/include/counter.php on line 10